Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03966417
Other study ID # UKCLFitTAVI
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date June 18, 2019
Est. completion date December 1, 2020

Study information

Verified date October 2022
Source University Medical Centre Ljubljana
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

In this prospective, controlled trial, patient after TAVI will be randomized to either exercise training or usual care group.


Description:

Patients after transcatheter aortic valve replacement (TAVI) are particularly old and severely deconditioned and are thus likely to benefit from cardiac rehabilitation programs. In this controlled trial, patients after TAVI will be randomized to either exercise training or usual care. The aim of our study is to compare the effect of exercise training vs. usual care on: 1. exercise capacity 2. vascular function 3. parameters of heart failure, inflammation and homeostasis 4. arrhythmogenic potential 5. health-related quality of life


Recruitment information / eligibility

Status Completed
Enrollment 30
Est. completion date December 1, 2020
Est. primary completion date October 1, 2020
Accepts healthy volunteers No
Gender All
Age group 18 Years to 99 Years
Eligibility Inclusion Criteria: - TAVI procedure 3-6 months prior to inclusion, - movability (100 meters or more on 6-minute walking test after TAVI), - ability to attend a 12 week exercise training program, - physical and clinical ability to attend the rehabilitation program at the discretion of the researcher, - optimal medical treatment, - pre-signed statement of a conscious and free consent to the inclusion in the clinical trial. Exclusion Criteria: - contraindications for exercise training, - unstable hearth (uncontrollable heart failure - New York Heart Association stage IV, dysrhythmias, uncontrollable myocardial ischemia), - patient's decision to undergo TAVI despite receiving a recommendation for Surgical Aortic Valve Repair by the heart team, - non-cardiac physical impairment that would prevent exercise training on stationary bike, - uncontrolled pulmonary disease (FEV1 <50%), - echocardiographic signs of prosthesis dysfunction according to the Valve Academic Research Consortium (valve orifice area of b1.2 cm2 plus a mean transaortic pressure gradient of =20 mm Hg, or a velocity of =3 m/s, at least moderate paravalvular regurgitation), - TAVI access site complication, - important peripheral vascular disease, musculoskeletal disease or central nervous system disease, which prevents exercise training on stationary bike, - recent (less than 3 months) acute events or illnesses that are contraindications for exercise training.

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Exercise training
Continuous exercise training 2 times per week for a period of 12 weeks.

Locations

Country Name City State
Slovenia UMC Ljubljana Ljubljana

Sponsors (1)

Lead Sponsor Collaborator
University Medical Centre Ljubljana

Country where clinical trial is conducted

Slovenia, 

References & Publications (7)

Butchart EG, Gohlke-Bärwolf C, Antunes MJ, Tornos P, De Caterina R, Cormier B, Prendergast B, Iung B, Bjornstad H, Leport C, Hall RJ, Vahanian A; Working Groups on Valvular Heart Disease, Thrombosis, and Cardiac Rehabilitation and Exercise Physiology, European Society of Cardiology. Recommendations for the management of patients after heart valve surgery. Eur Heart J. 2005 Nov;26(22):2463-71. Epub 2005 Aug 15. — View Citation

Chakos A, Wilson-Smith A, Arora S, Nguyen TC, Dhoble A, Tarantini G, Thielmann M, Vavalle JP, Wendt D, Yan TD, Tian DH. Long term outcomes of transcatheter aortic valve implantation (TAVI): a systematic review of 5-year survival and beyond. Ann Cardiothorac Surg. 2017 Sep;6(5):432-443. doi: 10.21037/acs.2017.09.10. Review. — View Citation

Dalal HM, Doherty P, Taylor RS. Cardiac rehabilitation. BMJ. 2015 Sep 29;351:h5000. doi: 10.1136/bmj.h5000. Review. — View Citation

McMahon SR, Ades PA, Thompson PD. The role of cardiac rehabilitation in patients with heart disease. Trends Cardiovasc Med. 2017 Aug;27(6):420-425. doi: 10.1016/j.tcm.2017.02.005. Epub 2017 Feb 15. Review. — View Citation

Pressler A, Christle JW, Lechner B, Grabs V, Haller B, Hettich I, Jochheim D, Mehilli J, Lange R, Bleiziffer S, Halle M. Exercise training improves exercise capacity and quality of life after transcatheter aortic valve implantation: A randomized pilot trial. Am Heart J. 2016 Dec;182:44-53. doi: 10.1016/j.ahj.2016.08.007. Epub 2016 Aug 26. — View Citation

Russo N, Compostella L, Tarantini G, Setzu T, Napodano M, Bottio T, D'Onofrio A, Isabella G, Gerosa G, Iliceto S, Bellotto F. Cardiac rehabilitation after transcatheter versus surgical prosthetic valve implantation for aortic stenosis in the elderly. Eur J Prev Cardiol. 2014 Nov;21(11):1341-8. doi: 10.1177/2047487313494029. Epub 2013 Jun 11. — View Citation

Völler H, Salzwedel A, Nitardy A, Buhlert H, Treszl A, Wegscheider K. Effect of cardiac rehabilitation on functional and emotional status in patients after transcatheter aortic-valve implantation. Eur J Prev Cardiol. 2015 May;22(5):568-74. doi: 10.1177/2047487314526072. Epub 2014 Feb 27. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Other Change of heart rate recovery beats/min 3 months
Primary Change of maximal oxygen uptake during exercise ml/kg/min 3 months
Secondary Change of flow-mediated dilatation (FMD) of the brachial artery % flow-mediated dilatation and arterial stiffness 3 months
Secondary Change of arterial stiffness coefficient coefficient 3 months
Secondary Change of value of blood N terminal-proBNP ng/l 3 months
Secondary Change of value of blood D-dimer microg/l 3 months
Secondary Change of value from-the-questionnaire-obtained quality of life points 3 months
Secondary Change of ECG waves Estimated with digital high-resolution ECG 3 months
Secondary Change in the result of the 6-minute walking test metres 3 months
Secondary Change og the heart rate variability Estimated with digital high-resolution ECG 3 months
See also
  Status Clinical Trial Phase
Completed NCT03186339 - Validation of the "TASQ" in Patients Undergoing SAVR or TF-TAVI
Recruiting NCT03549559 - Imaging Histone Deacetylase in the Heart N/A
Terminated NCT02854319 - REpositionable Percutaneous Replacement of NatIve StEnotic Aortic Valve Through Implantation of LOTUS EDGE Valve System N/A
Recruiting NCT05601453 - The ReTAVI Prospective Observational Registry
Withdrawn NCT05481814 - CPX in Paradoxical Low Flow Aortic Stenosis
Completed NCT02241109 - Predicting Aortic Stenosis Progression by Measuring Serum Calcification Propensity N/A
Completed NCT01700439 - Surgical Treatment of Aortic Stenosis With a Next Generation, Rapid Deployment Surgical Aortic Valve N/A
Recruiting NCT04429035 - SLOW-Slower Progress of caLcificatiOn With Vitamin K2 N/A
Completed NCT04103931 - Impact of a Patient Decision Aid for Treatment of Aortic Stenosis N/A
Completed NCT03950440 - Assessing the Incidence of Postoperative Delirium Following Aortic Valve Replacement
Active, not recruiting NCT02661451 - Transcatheter Aortic Valve Replacement to UNload the Left Ventricle in Patients With ADvanced Heart Failure (TAVR UNLOAD) N/A
Completed NCT02847546 - Evaluation of the BARD® True™ Flow Valvuloplasty Perfusion Catheter for Aortic Valve Dilatation N/A
Completed NCT02792452 - Clinical Value of Stress Echocardiography in Moderate Aortic Stenosis
Completed NCT02758964 - Evaluation of Cerebral Thrombembolism After TAVR
Not yet recruiting NCT02541877 - Sizing-sTrategy of Bicuspid AoRtic Valve Stenosis With Transcatheter Self-expandable Valve Phase 3
Not yet recruiting NCT02536703 - Safety and Efficacy of Lotus Valve For TAVI In Patients With Severe Aortic Stenosis In Chinese Population Phase 3
Active, not recruiting NCT02249000 - BIOVALVE - I / II Clincial Investigation N/A
Not yet recruiting NCT02221921 - Safety and Efficacy Study of MicroPort's Transcatheter Aortic Valve and Delivery System for TAVI N/A
Active, not recruiting NCT02080299 - Protection by Remote Ischemic Preconditioning During Transcatheter Aortic Valve Implantation Phase 2
Terminated NCT01939678 - Characterization and Role of Mutations in Sodium-phosphate Cotransporters in Patients With Calcific Aortic Valve Disease